Inflammation and chagas disease: Some mechanisms and relevance

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 171-194

  Talvani, André ^a   Teixeira, Mauro M ^b  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chagas heart disease; Chemokines; Inflammation; Inflammatory mediators; Trypanosoma cruzi

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ENDOTHELIN 1; GAMMA INTERFERON; INTERLEUKIN 12; LEUKOTRIENE B4; NITRIC OXIDE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BOOK; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CYTOKINE PRODUCTION; DISEASE MODEL; EXPERIMENTAL MODEL; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; INFLAMMATION; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

MAMMALIA; MASTIGOPHORA (FLAGELLATES); TRYPANOSOMA CRUZI;

EID: 80052157873     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00008-6     Document Type: Chapter

References (116)

1. Abdalla G.K., Faria G.E., Silva K.T., Castro E.C., Reis M.A., Michelin M.A. Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Exp. Parasitol. 2008, 118:514-521.
2. Abraham D., Distler O. How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res. Ther. 2007, 9:S2.
3. Aliberti J.C., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., et al. Beta-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect. Immun. 1999, 67:4819-4826.
4. Aliberti J.C.S., Souto J.T., Marino A.P.M.P., Lannes-Vieira J., Teixeira M.M., Farber J., et al. Modulation of chemokine production and inflammatory responses in interferon-g and-tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am. J. Pathol. 2001, 158:1433-1440.
5. Aparecida da Silva C., Fattori A., Sousa A.L., Mazon S.B., Monte Alegre S., Almeida E.A., et al. Determining the C-reactive protein level in patients with different clinical forms of Chagas disease. Rev. Esp. Cardiol. 2010, 63:1096-1099.
6. Araujo F.F., Gomes J.A., Rocha M.O., Williams-Blangero S., Pinheiro V.M., Morato M.J., et al. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front. Biosci. 2007, 12:2797-2806.
7. Araújo-Jorge T.C., Waghabi M.C., Soeiro Mde N., Keramidas M., Bailly S., Feige J.J. Pivotal role for TGF-beta in infectious heart disease: the case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. Cytokine Growth Factor Rev. 2008, 19:405-413.
8. Bacal F., Silva C.P., Pires P.V., Mangini S., Fiorelli A.I., Stolf N.G., et al. Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades. Clin. Transplant. 2010, 24:E29-E34.
9. Bafica A., Santiago H.C., Goldszmid R., Ropert C., Gazzinelli R.T., Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 2006, 177:3515-3519.
10. Bastos K.R., Barboza R., Sardinha L., Russo M., Alvarez J.M., Lima M.R. Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. J. Interferon Cytokine Res. 2007, 27:399-410.
11. Ben Younès-Chennoufi A., Hontebeyrie-Joskowicz M., Tricottet V., Eisen H., Reynes M., Said G. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans. R. Soc. Trop. Med. Hyg. 1988, 82:77-83.
12. Benvenuti L.A., Roggério A., Freitas H.F., Mansur A.J., Fiorelli A., Higuchi M.L. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann. Trop. Med. Parasitol. 2008, 102:481-487.
13. Bértoli M., Andó M.H., DeOrnelas-Toledo M.J., De Araújo S.M., Gomes M.L. Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts. Parasitol. Res. 2006, 99:7-13.
14. Bilate A.M., Salemi V.M., Ramires F.J., de Brito T., Russo M., Fonseca S.G., et al. TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect. 2007, 9:1104-1113.
15. Borges C.L., Cecchini R., Tatakihara V.L., Malvezi A.D., Yamada-Ogatta S.F., Rizzo L.V., et al. 5-lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Immunol. Lett. 2009, 123:38-45.
16. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 1997, 114:103-110.
17. Calzada J.E., Nieto A., Beraún Y., Martín J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001, 58:154-158.
18. Camargo M.M., Almeida I.C., Pereira M.A., Ferguson M.A.J., Travassos L.R., Gazzinelli R.T. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 1997, 158:5890-5901.
19. Camargos E.R., Rocha L.L., Rachid M.A., Almeida A.P., Ferreira A.J., Teixeira A.L., et al. Protective role of ETA endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats. Microbes Infect. 2004, 6:650-656.
20. Campos M.A., Gazzinelli R.T. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through toll-like receptors. Mediators Inflamm. 2004, 13:139-143.
21. Carvalho C.M., Andrade M.C., Xavier S.S., Mangia R.H., Britto C.C., Jansen A.M., et al. Chronic Chagas' disease in rhesus monkeys (Macaca mulatta): evaluation of parasitemia, serology, electrocardiography, echocardiography, and radiology. Am. J. Trop. Med. Hyg. 2003, 68:683-691.
22. Chandra M., Tanowitz H.B., Petkova S.B., Huang H., Weiss L.M., Wittner M., et al. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int. J. Parasitol. 2002, 32:897-905.
23. Chandra M., Shirani J., Shtutin V., Weiss L.M., Factor S.M., Petkova S.B., et al. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study. Int. J. Parasitol. 2002, 32:207-215.
24. Clark I.A., Rockett K.A. Nitric oxide and parasitic disease. Adv. Parasitol. 1996, 37:1-55.
25. Coelho P.S., Klein A., Talvani A., Coutinho S.F., Takeuchi O., Akira S., et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-gamma-primed-macrophages. J. Leukoc. Biol. 2002, 71:837-844.
26. Costa S.C. Mouse as a model for Chagas disease: does mouse represent a good model for Chagas disease?. Mem. Inst. Oswaldo Cruz 1999, 94:269-272.
27. Costa G.C., da Costa Rocha M.O., Moreira P.R., Menezes C.A., Silva M.R., Gollob K.J., et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J. Infect. Dis. 2009, 199:451-454.
28. Cunha-Neto E., Nogueira L.G., Teixeira P.C., Ramasawmy R., Drigo S.A., Goldeberg A.C., et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem. Inst. Oswaldo Cruz 2009, 104:252-258.
29. de Oliveira G.M., Diniz R.L., Batista W., Batista M.M., Bani Correa C., de Araújo-Jorge T.C., et al. Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. Am. J. Pathol. 2007, 171:79-86.
30. de Lana M., Chiari E., Tafuri W.L. Experimental Chagas' disease in dogs. Mem. Inst. Oswaldo Cruz 1992, 87:59-71.
31. Diniz L.F., Caldas I.S., Guedes P.M., Crepalde G., deLana M., Carneiro C.M., et al. Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi. Antimicrob. Agents Chemother. 2010, 54:2979-2986.
32. Dos Santos P.V., Roffe E., Santiago H.C., Torres R.A., Marino A.P., Paiva C.N., et al. Prevalence of CD8(+) alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L (low), LFA-1(high), VLA-4(high) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes Infect. 2001, 3:971-984.
33. Durand J.L., Tang B., Gutstein D.E., Petkova S., Teixeira M.M., Tanowitz H.B., et al. Dyskinesis in chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. J. Magn. Reson. Imaging 2006, 24:1051-1057.
34. Durand J.L., Mukherjee S., Commodari F., De Souza A.P., Zhao D., Machado F.S., et al. Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice. Am. J. Trop. Med. Hyg. 2009, 80:782-787.
35. Dutra W.O., Rocha M.O., Teixeira M.M. The clinical immunology of human Chagas disease. Trends Parasitol. 2005, 21:581-587.
36. Fernandez-Mestre M.T., Montagnani S., Layrisse Z. Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?. Hum. Immunol. 2004, 65:725-728.
37. Garcia S., Ramos C.O., Senra J.F., Vilas-Boas F., Rodrigues M.M., Campos-de-Carvalho A.C., et al. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrob. Agents Chemother. 2005, 49:1521-1528.
38. Garcia C.C., Guabiraba R., Soriani F.M., Teixeira M.M. The development of anti-inflammatory drugs for infectious diseases. Discov. Med. 2010, 55:479-488.
39. Garside P., Brewer J. In vivo imaging of infection immunology-4I's!. Semin. Immunopathol. 2010, 32:289-296.
40. Golgher D., Gazzinelli R.T. Innate and acquired immunity in the pathogenesis of Chagas disease. Autoimmunity 2004, 37:399-409.
41. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas's disease is due to a Th1-specific immune response. Infect. Immun. 2003, 71:1185-1193.
42. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Busek S.C., Teixeira M.M., Silva J.S., et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect. Immun. 2005, 73:7960-7966.
43. Guedes P.M., Veloso V.M., Tafuri W.L., Galvão L.M., Carneiro C.M., Lana M., et al. The dog as model for chemotherapy of the Chagas' disease. Acta Trop. 2002, 84:9-17.
44. Guedes P.M., Veloso V.M., Talvani A., Diniz L.F., Caldas I.S., Do-Valle-Matta M.A., et al. Increased type 1 chemokine expression in experimental Chagas disease correlates with cardiac pathology in Beagle dogs. Vet. Immunol. Immunopathol. 2010, 138:106-113.
45. Guillermo L.V., Silva E.M., Ribeiro-Gomes F.L., De Meis J., Pereira W.F., Yagita H., et al. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J. Leukoc. Biol. 2007, 81:942-951.
46. Gutierrez F.R., Lalu M.M., Mariano F.S., Milanezi C.M., Cena J., Gerlach R.F., et al. Increased activities of cardiac matrix metalloproteinases (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J. Infect. Dis. 2008, 15:1468-1476.
47. Hardison J.L., Wrightsman R.A., Carpenter P.M., Kuziel W.A., Lane T.E., Manning J.E. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect. Immun. 2006, 74:135-143.
48. Hori S., Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 2004, 6:745-751.
49. Jelicks L.A., Chandra M., Shirani J., Shtutin V., Tang B., Christ G.J., et al. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int. J. Parasitol. 2002, 32:1497-1506.
50. Koga R., Hamano S., Kuwata H., Atarashi K., Ogawa M., Hisaeda H., et al. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J. Immunol. 2006, 177:7059-7066.
51. Laranja F.S., Andrade Z.A. Chronic cardiac form of Chagas disease in dogs. Arq. Bras. Cardiol. 1980, 35:377-380.
52. Le Y., Zhou Y., Iribarren P., Wang J. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell. Mol. Immunol. 2004, 1:95-104.
53. López L., Arai K., Giménez E., Jiménez M., Pascuzo C., Rodríguez-Bonfante C., et al. C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure. Rev. Esp. Cardiol. 2006, 59:50-56.
54. Lula J.F., Rocha M.O., Nunes Mdo C., Ribeiro A.L., Teixeira M.M., Bahia M.T., et al. Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction. Eur. J. Heart Fail. 2009, 11:825-831.
55. Machado F.S., Koyama N.S., Carregaro V., Ferreira B.R., Milanezi C.M., Teixeira M.M., et al. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 2005, 191:627-636.
56. Machado F.S., Souto J.T., Rossi M.A., Esper L., Tanowitz H.B., Aliberti J., et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect. 2008, 10:1558-1566.
57. Mariano F.S., Gutierrez F.R., Pavanelli W.R., Milanezi C.M., Cavassani K.A., Moreira A.P., et al. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect. 2008, 10:825-833.
58. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., Simões M.V. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123.
59. Marino A.P., da Silva A., dos Santos P., Pinto L.M., Gazzinelli R.T., Teixeira M.M., et al. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 2004, 110:1443-1449.
60. Marino A.P., Silva A.A., Santos P.V., Pinto L.M., Gazinelli R.T., Teixeira M.M., et al. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem. Inst. Oswaldo Cruz 2005, 100:93-96.
61. McGettrick A.F., O'Neill L.A. Localisation and trafficking of toll-like receptors: an important mode of regulation. Curr. Opin. Immunol. 2010, 22:20-27.
62. Melo Coutinho C.M., Cavalcanti G.H., Bonaldo M.C., Mortensen R.F., Araújo-Jorge T.C. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein. Exp. Parasitol. 1998, 90:143-153.
63. Melo L., Caldas I.S., Azevedo M.A., Gonçalves K.R., Nascimento A.F.S., Figueiredo V.P., et al. Low doses of Simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs. Am. J. Trop. Med. Hyg. 2011, 84:325-331.
64. Moreira Mda C., Heringer-Walther S., Wessel N., Moreira Ventura T., Wang Y., Schultheiss H.P., et al. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Cardiology 2008, 110:217-225.
65. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 1994, 12:593-633.
66. Nagajyothi F., Desruisseaux M.S., Thiruvur N., Weiss L.M., Braunstein V.L., Albanese C., et al. Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity 2008, 16:1992-1997.
67. Nagajyothi F., Desruisseaux M.S., Weiss L.M., Chua S., Albanese C., Machado F.S., et al. Chagas disease, adipose tissue and the metabolic syndrome. Mem. Inst. Oswaldo Cruz 2009, 104:219-225.
68. Nogueira de Melo A.C., de Souza E.P., Elias C.G., dos Santos A.L., Branquinha M.H., d'Avila-Levy C.M., et al. Detection of matrix metallopeptidase-9-like proteins in Trypanosoma cruzi. Exp. Parasitol. 2010, 125:256-263.
69. Oliveira A.C., Peixoto J.R., Arruda L.B., Campos M.A., Gazzinelli R.T., Golenbock D.T., et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 2004, 173:5688-5696.
70. Paiva C.N., Figueiredo R.T., Kroll-Palhares K., Silva A.A., Silvério J.C., Gibaldi D., et al. CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. J. Leukoc. Biol. 2009, 86:1239-1246.
71. Panis C., Mazzuco T.L., Costa C.Z., Victorino V.J., Tatakihara V.L., Yamauchi L.M., et al. Trypanosoma cruzi: effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice. Exp. Parasitol. 2011, 127:58-65.
72. Pascutti M.F., Bottasso O.A., Hourquescos M.C., Wietzerbin J., Revelli S. Age-related increase in resistance to acute Trypanosoma cruzi infection in rats is associated with an appropriate antibody response. Scand. J. Immunol. 2003, 58:173-179.
73. Paula-Costa G., Silva R.R., Pedrosa M.C., Pinho V., de Lima W.G., Teixeira M.M., et al. Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease. Parasite Immunol. 2010, 32:202-208.
74. Pavanelli W.R., Gutierrez F.R., Mariano F.S., Prado C.M., Ferreira B.R., Teixeira M.M., et al. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect. 2010, 12:587-597.
75. Petersen C.A., Krumholz K.A., Burleigh B.A. Toll-like receptor 2 regulates interleukin-1β-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect. Immun. 2005, 73:6974-6980.
76. Petkova S.B., Tanowitz H.B., Magazine H.I., Factor S.M., Chan J., Pestell R.G., et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 2000, 9:257-265.
77. Rachid M.A., Camargos E.R., Barcellos L., Marques C.A., Chiari E., Huang H., et al. Blockade of endothelin ET(A)/ET(B) receptors favors a role for endothelin during acute Trypanosoma cruzi infection in rats. Microbes Infect. 2006, 8:2113-2119.
78. Rachid M.A., Teixeira A.L., Barcelos L.S., Machado C.R., Chiari E., Tanowitz H.B., et al. Role of endothelin receptors in the control of central nervous system parasitism in Trypanosoma cruzi infection in rats. J. Neuroimmunol. 2010, 220:64-68.
79. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Müller N.G., Cavalcanti V.L., et al. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clin. Infect. Dis. 2006, 43:305-311.
80. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Gazzinelli G., Colley D.G., et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 1993, 48:637-644.
81. Ribeiro A.L., dos Reis A.M., Barros M.V., de Sousa M.R., Rocha A.L., Perez A.A., et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet 2002, 360:461-462.
82. Ribeiro A.L., Teixeira M.M., Reis A.M., Talvani A., Perez A.A., Barros M.V., et al. Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. Int. J. Cardiol. 2006, 109:34-40.
83. Rocha e Silva M. A brief survey of the history of inflammation. Agents Actions 1978, 43:86-90.
84. Rocha M.O., Teixeira M.M., Ribeiro A.L. An update on the management of Chagas cardiomyopathy. Expert Rev. Anti Infect. Ther. 2007, 5:727-743.
85. Rodrigues C.O., Dutra P.M., Barros F.S., Souto-Padrón T., Meyer-Fernandes J.R., Lopes A.H. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 1999, 266:36-42.
86. Rodrigues V., Agrelli G.S., Leon S.C., Silva Teixeira D.N., Tostes S., Rocha-Rodrigues D.B. Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect. 2008, 10:29-37.
87. Roffê E., Souza A.L., Caetano B.C., Machado P.P., Barcelos L.S., Russo R.C., et al. A DNA vaccine encoding CCL4/MIP-1beta enhances myocarditis in experimental Trypanosoma cruzi infection in rats. Microbes Infect. 2006, 8:2745-2755.
88. Roffê E., Oliveira F., Souza A.L., Pinho V., Souza D.G., Souza P.R., et al. Role of CCL3/MIP-1alpha and CCL5/RANTES during acute Trypanosoma cruzi infection in rats. Microbes Infect. 2010, 12:669-676.
89. Romanha A.J., Castro S.L., Soeiro Mde N., Lannes-Vieira J., Ribeiro I., Talvani A., et al. In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem. Inst. Oswaldo Cruz 2010, 105:233-238.
90. Ropert C., Gazzinelli R.T. Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa. Curr. Opin. Microbiol. 2000, 3:395-403.
91. Salomone O.A., Caeiro T.F., Madoery R.J., Amuchástegui M., Omelinauk M., Juri D., et al. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am. J. Cardiol. 2001, 87:1217-1220.
92. Sigusch H.H., Lehmann M.H., Reinhardt D., Henke A., Zell R., Leipner C., et al. Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy. Pharmazie 2006, 61:706-709.
93. Silva J.S., Twardzic D.R., Reed S.G. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-β). J. Exp. Med. 1991, 174:539-545.
94. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 1992, 175:169-174.
95. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C.S., Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 1995, 63:4862-4867.
96. Silva J.S., Machado F.S., Martins G.A. The role of nitric oxide in the pathogenesis of Chagas disease. Front. Biosci. 2003, 8:s314-s325.
97. Silva G.K., Gutierrez F.R., Guedes P.M., Horta C.V., Cunha L.D., Mineo T.W., et al. Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J. Immunol. 2010, 184:1148-1152.
98. Silverio J.C., de-Oliveira-Pinto L.M., da Silva A.A., de Oliveira G.M., Lannes-Vieira J. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection. Int. J. Exp. Pathol. 2010, 91:72-86.
99. Soares M.B., de Lima R.S., Rocha L.L., Vasconcelos J.F., Rogatto S.R., dos Santos R.R., et al. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J. Infect. Dis. 2010, 202:416-426.
100. Sorokin L. The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 2010, 10:712-723.
101. Sterin-Borda L., Gorelik G., Goren N., Cappa S.G., Celentano A.M., Borda E. Lymphocyte muscarinic cholinergic activity and PGE2 involvement in experimental Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 1996, 81:122-128.
102. Stumpf C., Lehner C., Raaz D., Yilmaz A., Anger T., Daniel W.G., et al. Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure. Heart 2008, 94:65-69.
103. Talvani A., Ribeiro C.S., Aliberti J.C., Michailowsky V., Santos P.V., Murta S.M., et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. 2000, 2:851-866.
104. Talvani A., Machado F.S., Santana G.C., Klein A., Barcelos L., Silva J.S., et al. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 2002, 70:4247-4253.
105. Talvani A., Santana G., Barcelos L.S., Ishii S., Shimizu T., Romanha A.J., et al. Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice. Microbes Infect. 2003, 5:789-796.
106. Talvani A., Rocha M.O., Ribeiro A.L., Correa-Oliveira R., Teixeira M.M. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J. Infect. Dis. 2004, 189:214-220.
107. Talvani A., Rocha M.O., Barcelos L.S., Gomes Y.M., Ribeiro A.L., Teixeira M.M. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin. Infect. Dis. 2004, 38:943-950.
108. Talvani A., Rocha M.O., Cogan J., Maewal P., de Lemos J., Ribeiro A.L., et al. Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem. Inst. Oswaldo Cruz 2004, 99:645-649.
109. Talvani A., Coutinho S.F., Barcelos L.S., Teixeira M.M. Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins. Parasitol. Res. 2009, 104:1141-1148.
110. Tanowitz H.B., Huang H., Jelicks L.A., Chandra M., Loredo M.L., Weiss L.M., et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect. Immun. 2005, 73:2496-2503.
111. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 2002, 18:262-265.
112. Vespa G.N.R., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 1994, 62:5177-5182.
113. Waghabi M.C., de Souza E.M., de Oliveira G.M., Keramidas M., Feige J.J., Araújo-Jorge T.C., et al. Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease. Antimicrob. Agents Chemother. 2009, 53:4694-4701.
114. Waghabi M.C., Coutinho-Silva R., Feige J.J., Higuchi Mde L., Becker D., Burnstock G., et al. Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 2009, 104:1083-1090.
115. Wirth J.J., Kierszenbaum F. Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. J. Immunol. 1985, 134:1989-1993.
116. Yamauchi L.M., Aliberti J.C., Baruffi M.D., Portela R.W., Rossi M.A., Gazzinelli R.T., et al. The binding of CCL2 to the surface of Trypanosoma cruzi induces chemo-attraction and morphogenesis. Microbes Infect. 2007, 9:111-118.